These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 23141215)

  • 21. Oestrogen and progesterone receptor expression in subtypes of canine mammary tumours in intact and ovariectomised dogs.
    Mainenti M; Rasotto R; Carnier P; Zappulli V
    Vet J; 2014 Oct; 202(1):62-8. PubMed ID: 24980810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and prognostic value of c-met in canine mammary tumours.
    Chen YC; Chen YY; Liao JW; Chang SC
    Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
    Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
    J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caveolin-1 in diagnosis and prognosis of canine mammary tumours: comparison of evaluation systems.
    Pereira PD; Lopes CC; Matos AJ; Cortez PP; Gärtner F; Medeiros R; Lopes C
    J Comp Pathol; 2010; 143(2-3):87-93. PubMed ID: 20153868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E-cadherin immunohistochemical expression in mammary gland neoplasms in bitches.
    Rodo A; Malicka E
    Pol J Vet Sci; 2008; 11(1):47-54. PubMed ID: 18540208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of CD44 adhesion factor in canine mammary carcinomas.
    Madrazo J; García-Fernández RA; García-Iglesias MJ; Durán AJ; Espinosa J; Pérez-Martínez C
    Vet J; 2009 Jun; 180(3):371-6. PubMed ID: 18299241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of HER-2 in feline invasive mammary carcinomas: an immunohistochemical survey and evaluation of its prognostic potential.
    Millanta F; Calandrella M; Citi S; Della Santa D; Poli A
    Vet Pathol; 2005 Jan; 42(1):30-4. PubMed ID: 15657269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study.
    Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C
    J Comp Pathol; 2014; 150(2-3):184-93. PubMed ID: 24225342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical evaluation of STAT3-p-tyr705 expression in feline mammary gland tumours and correlation with histologic grade.
    Petterino C; Ratto A; Podestà G; Drigo M; Pellegrino C
    Res Vet Sci; 2007 Apr; 82(2):218-24. PubMed ID: 16934302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decorin concentrations in canine normal and neoplastic mammary gland tissues.
    Szczubiał M; Kankofer M; Wawrzykowski J; Dąbrowski R; Łopuszyński W; Bochniarz M; Brodzki P
    Reprod Domest Anim; 2020 Oct; 55(10):1404-1410. PubMed ID: 33470009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p63: a novel myoepithelial cell marker in canine mammary tissues.
    Gama A; Alves A; Gartner F; Schmitt F
    Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucin 6 and Tn antigen expression in canine mammary tumours: correlation with pathological features.
    Tavares C; de Oliveira JT; Lopes C; Carvalheira J; Matos AJ; Rutteman G; Reis CA; Gärtner F
    J Comp Pathol; 2012 Nov; 147(4):410-8. PubMed ID: 22595635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible role of Snail expression as a prognostic factor in canine mammary neoplasia.
    Im KS; Kim JH; Kim NH; Yu CH; Hur TY; Sur JH
    J Comp Pathol; 2012; 147(2-3):121-8. PubMed ID: 22297072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen receptor expression in normal, hyperplastic and neoplastic hepatoid glands in the dog.
    Pisani G; Millanta F; Lorenzi D; Vannozzi I; Poli A
    Res Vet Sci; 2006 Oct; 81(2):231-6. PubMed ID: 16427103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased presence of stromal myofibroblasts and tenascin-C with malignant progression in canine mammary tumors.
    Yoshimura H; Michishita M; Ohkusu-Tsukada K; Takahashi K
    Vet Pathol; 2011 Jan; 48(1):313-21. PubMed ID: 20571146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of Cox-1 and Cox-2 in canine mammary tumours.
    Queiroga FL; Alves A; Pires I; Lopes C
    J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of tissue factor in canine mammary tumours and correlation with grade, stage and markers of haemostasis and inflammation.
    Andreasen EB; Nielsen OL; Tranholm M; Knudsen T; Kristensen AT
    Vet Comp Oncol; 2016 Jun; 14(2):191-201. PubMed ID: 24674618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.
    Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F
    BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue--an immunohistochemical study.
    Dias Pereira P; Carvalheira J; Gärtner F
    Vet J; 2004 Sep; 168(2):180-5. PubMed ID: 15301767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metallothionein expression in canine and feline mammary and melanotic tumours.
    Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
    J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.